A pharmacovigilance study utilizing the FDA Adverse Event Reporting Sy

Introduction

Migraine is a common neurological disorder impacting about 14% of people worldwide, with a higher reporting frequency in women.¹ Triptans, as selective serotonin 5-HT(1B/1D) receptor agonists, are commonly prescribed as the primary…